Evidence map›Paper›PMID 39494721›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Aloe Emodin Alleviates Radiation-Induced Heart Disease via Blocking P4HB Lactylation and Mitigating Kynurenine Metabolic Disruption.

Fan Ouyang, Yaling Li, Haoming Wang, Xiangyang Liu, Xiaoli Tan, Genyuan Xie, Junfa Zeng, Gaofeng Zeng, Qiong Luo, Hong Zhou and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Integrated Multiomic Analysis Reveals the Therapeutic Potential of Danhong Injection in Mitigating Radiation-Induced Heart Disease by Modulating Ferroptosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Fan OuyangDepartment of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, 412000, P. R. China.
Yaling LiDepartment of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, 412000, P. R. China.
Haoming WangDepartment of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, 412000, P. R. China.
Xiangyang LiuDepartment of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, 412000, P. R. China.
Xiaoli TanZhuzhou Clinical College, Jishou University, Jishou, Hunan, 416000, P. R. China.
Genyuan XieZhuzhou Clinical College, Jishou University, Jishou, Hunan, 416000, P. R. China.
Junfa ZengDepartment of Critical Care Medicine, Hengyang Medical School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, P. R. China.
Gaofeng ZengClinical Research Institute, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.
Qiong LuoClinical Research Center for Arteriosclerotic Disease in Hunan Province, Hengyang, Hunan, 421001, P. R. China.
Hong ZhouDepartment of Radiology, Hengyang Medical School, The First Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, P. R. China.
Siming ChenClinical Research Center for Arteriosclerotic Disease in Hunan Province, Hengyang, Hunan, 421001, P. R. China.
Kai HouDepartment of Cardiovascular Medicine, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.
Jinren FangDepartment of Cardiovascular Medicine, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.
Xia ZhangDepartment of Ultrasound Medicine, Hengyang Medical School, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, P. R. China.
Linlin ZhouZhuzhou Clinical College, Jishou University, Jishou, Hunan, 416000, P. R. China.
Yukun LiDepartment of Assisted Reproductive Centre, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, 412000, P. R. China.
Anbo GaoClinical Research Institute, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.ORCID 0009-0007-6564-3495

Funding

Clinical Research 4310 Program of the First Affiliated Hospital of University of South China 20224310NHYCG03Foundation of Hunan Provincial Key Laboratory 2023TP1014Hengyang Science and Technology Plan Special Fund 2019jh426001Hunan Provincial Postdoctoral Science Foundation 2020SK4010Hunan Provincial Postdoctoral Science Foundation 2022JJ40386Hunan Provincial Postdoctoral Science Foundation 2023JJ40573Hunan Provincial Postdoctoral Science Foundation 2023JJ40578Hunan Provincial Postdoctoral Science Foundation 2023JJ40579Hunan Provincial Postdoctoral Science Foundation 2023JJ41066Hunan Provincial Postdoctoral Science Foundation 2023JJ60048Hunan Provincial Postdoctoral Science Foundation 2024JJ9383Hunan Provincial Postdoctoral Science Foundation S2022JJSSLH0406Key Guidance Projects for University of South China nk2020106National Natural Science Foundation of China 82070426National Natural Science Foundation of China 82303246National Natural Science Foundation of China 82304076Research Start-up Fund of the Second Affiliated Hospital of Hengyang Medical College of University of South China 2021B02Scientific Research Project of Hunan Provincial Department of Education 21B0407Scientific Research Project of Hunan Provincial Health Commission of China 202203013975Scientific Research Project of Yun'nan Provincial Department of Education 2022J1522
6 · The paper itself

Abstract

Aloe emodin is an anthraquinone of traditional Chinese medicine monomer, which plays a protective action in cardiovascular diseases. However, the regulatory mechanisms of aloe emodin in the protection of radiation-induced heart damage (RIHD) are unclear. As a novel post-translational modification, lactylation is considered as a critical mediator in inflammatory cascade and cardiac injury. Here, using a cross of differential omics and 4D label-free lactylation omics, protein disulfide-isomerase (P4HB) is identified as a novel target for lactylation, and aloe emodin inhibits the binding of lactate to the K311 site of P4HB. Aloe emodin stabilizes kynurenine metabolism through inhibition of aspartate aminotransferase (GOT2) accumulation on damaged mitochondria. Mechanistically, aloe emodin inhibits phosphorylated glycogen synthase kinase 3B (p-GSK3B) transcription in the nucleus to repress the interaction of prostaglandin G/H synthase 2 (PTGS2) with SH3 domain of SH3 domain-containing GRB2-like protein B1 (SH3GLB1), thereby disrupting the functions of mitochondrial complexes and reducing SH3GLB1-mediated mitoROS accumulation, eventually suppressing calcium-binding and coiled-coil domain-containing protein 2 (NDP52)-induced mitophagy. This study unveils the regulatory role of aloe emodin in RIHD alleviation through PTGS2/SH3GLB1/NDP52 axis, indicates aloe emodin stabilizes GOT2-mediated kynurenine metabolism through P4HB lactylation. Collectively, this study provides novel insights into the regulatory mechanisms underlying the protective role of aloe emodin in cardiac injury, and opens new avenues for therapeutic strategies of aloe emodin in preventing RIHD by regulating lactylation.

Indexed as

KynurenineAnimalsAnthraquinonesDisease Models, AnimalHeart DiseasesMaleMicealoe emodinAnthraquinonesKynureninealoe emodinkynurenine metabolismlactylationmitophagyradiation‐induced heart damage

Identifiers

PMID39494721
PMCPMC11653682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.